Back to search
FDAFDA · Food and drugs·Recall number D-0222-2026

Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.

Published December 17, 2025 · Recall initiated: November 18, 2025

Summary

FDA records drug Class III recall D-0222-2026, published December 17, 2025 and initiated November 18, 2025. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Ongoing; Reported quantity: 672 90-count bottles; Lot: Lot# 17240988; Exp. 05/31/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with Other Products

What to do

Voluntary: Firm initiated · Letter

Get an email if NEBIVOLOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NEBIVOLOL
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Distributor
U.S. Nationwide
UPC
0342291872905
Lot
Lot# 17240988; Exp. 05/31/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90. recalled?

Yes. FDA published recall D-0222-2026 on December 17, 2025. Reported hazard: Cross Contamination with Other Products

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NEBIVOLOL. UPC: 0342291872905.